Company intelligence / Profile preview

Jeevan Therapeutics

Hyderabad, Telangana, Indiajeevantx.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Has completed over four hundred fifty studies with audits by CDSCO, US FDA, WHO among others. Offers integrated solutions for BA/BE studies, pharmacovigilance case processing, risk evaluation mitigation strategies. Recently accredited NABL lab enables most diagnostic tests in-house. Focuses on delivering high-quality CRO services with regulatory compliance.

Therapeutic areas: Oncology
Modalities: Clinical trial management from Phase II to IVBioanalytical studies including BA/BE studiesPharmacovigilance including ICSR management and risk management plansDiagnostic testing via NABL-accredited clinical pathology lab
Industry: Contract Research Organization

Beyond the preview

Go deeper on Jeevan Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jeevan Therapeutics.

Explore the full profile